Clinical Trial Update: The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort -

View source ↗

Summary

This clinical trial update evaluates the prevalence of neurocognitive disorder in a primary care-based HIV cohort compared with an HIV-negative control cohort.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Neurocognitive Disorder

Snippet

Sponsor: Holdsworth House Medical Practice | Conditions: HIV-1-Associated Cognitive Motor Complex | Status: COMPLETED